ARCHIVES

Amgen Cancels Rilotumumab Trials in Gastric Cancer

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

IARC Publishes Fourth Edition of European Code Against Cancer

October 17, 2014

SWOG Trial Reports Longest Survival To Date For NSCLC

June 29, 2001

FDA Advisors Unanimously Turn Down GPC Biotech’s Orplatna for Prostate Cancer.

July 27, 2007

Capitol Hill: Bills Seeks Coverage for Treatment Of cancers Found in CDC Screening

April 2, 1999

Rauscher Tells Flood Subcommittee How He Would Spend An Extra $50 Million-On Centers, Grants

April 5, 1974

UHC Expands Risk Models To Include 25 Cancer Variables

February 24, 2012